The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
azacitidine · Injection, Powder, For Solution
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 100 mg · Injection, Powder, Lyophilized, For Solution · #1 injection, powder, lyophilized, for solution/carton
What changed in the last 90 days
Every detected change for azacitidine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- AzacitidineAug 12, 2026Mfr exitedShanghai Huilun Jiangsu Pharmaceutical Co., Ltd. · azacitidine
- AzacitidineJul 18, 2026New productJiangsu Hansoh Pharmaceutical Group Co., Ltd.
Same drug class
Other molecules FDA puts in Nucleoside Metabolic Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- pentostatin· in shortage
- (daunorubicin and cytarabine) liposome· 1 maker
- azacitidine for· 1 maker
- fluorouracil cream, 0.5%· 1 maker
- gemcitabine intravesical· 1 maker
- purixan· 1 maker
- trifluridine and tipiracil· 1 maker
- cedazuridine and decitabine· 3 makers
- trifluridine· 6 makers
- mercaptopurine· 7 makers
- cytarabine· 9 makers
- fludarabine phosphate· 10 makers
Common questions
- Is Azacitidine in shortage right now?
- Yes. FDA currently lists Azacitidine in shortage. This page is rebuilt every morning from FDA's shortage database.
- Who makes Azacitidine?
- 36 companies have marketed Azacitidine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.